tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market
Holding HUMA?
Track your performance easily

Humacyte (HUMA) Financial Statements

943 Followers

Humacyte Financial Overview

Humacyte's market cap is currently ―. The company's EPS TTM is $-1.34; its P/E ratio is -3.29; Humacyte is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -39.20M$ -56.66M$ -30.08M$ -23.38M$ -24.53M
EBITDA$ -37.35M$ -54.93M$ -28.25M$ -21.55M$ -22.70M
Net Income Common Stockholders$ -39.20M$ -56.66M$ -31.90M$ -25.11M$ -26.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 20.57M$ 93.56M$ 115.50M$ 80.45M$ 99.99M
Total Assets$ 114.76M$ 138.28M$ 161.47M$ 128.22M$ 149.38M
Total Debt$ 79.38M$ 78.00M$ 76.53M$ 57.51M$ 56.78M
Net Debt$ 58.81M$ -15.56M$ -38.98M$ -22.94M$ -43.21M
Total Liabilities$ 178.49M$ 166.57M$ 135.31M$ 114.68M$ 112.39M
Stockholders Equity$ -63.72M$ -28.29M$ 26.15M$ 13.55M$ 36.99M
Cash Flow-
Free Cash Flow$ -23.88M$ -21.48M$ -27.69M$ -19.20M$ -13.50M
Operating Cash Flow$ -22.95M$ -21.30M$ -27.30M$ -19.05M$ -13.01M
Investing Cash Flow$ -934.00K$ -184.00K$ -391.00K$ -150.00K$ -493.00K
Financing Cash Flow$ 849.00K$ -467.00K$ 62.80M$ -335.00K$ -764.00K
Currency in USD

Humacyte Earnings and Revenue History

Humacyte Debt to Assets

Humacyte Cash Flow

Humacyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis